Literature DB >> 14734615

A mechanism underlying STAT4-mediated up-regulation of IFN-gamma induction inTCR-triggered T cells.

Woong-Ryeon Park1, Masakiyo Nakahira, Naotoshi Sugimoto, Yang Bian, Yumi Yashiro-Ohtani, Xu-Yu Zhou, Yi-Fu Yang, Toshiyuki Hamaoka, Hiromi Fujiwara.   

Abstract

IL-12 promotes T(h)1 development/IFN-gamma expression by activating STAT4. However, it is still unclear how STAT4 elicits IFN-gamma promoter activation. Here, we investigated the mechanism by which IL-12-activated STAT4 functions for IFN-gamma induction in TCR-triggered T cells. TCR stimulation induced high levels of IFN-gamma production depending on co-stimulation with IL-12. IL-12 stimulation greatly enhanced the promoter-binding activity of c-Jun/AP-1, a critical transcription factor for IFN-gamma gene expression in wild-type T cells, but not in STAT4-deficient (STAT4(-/-)) T cells. Comparable amounts of c-Jun were induced by TCR stimulation in both wild-type and STAT4(-/-) T cells irrespective of IL-12 co-stimulation. However, c-Jun bound to STAT4 in IL-12-co-stimulated wild-type T cells. c-Jun forming a complex with STAT4 efficiently interacted with the AP-1-related sequence of the IFN-gamma promoter. Such an enhanced c-Jun binding did not occur in STAT4(-/-) T cells. These results show that STAT4 contributes to enhancing IFN-gamma expression by up-regulating the binding of TCR signal-induced AP-1 to the relevant promoter sequence.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14734615     DOI: 10.1093/intimm/dxh034

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  15 in total

1.  Regulation of ITAM-positive receptors: role of IL-12 and IL-18.

Authors:  John R Ortaldo; Robin Winkler-Pickett; Jon Wigginton; Meagan Horner; Earl W Bere; Anna T Mason; Narayan Bhat; James Cherry; Michael Sanford; Deborah L Hodge; Howard A Young
Journal:  Blood       Date:  2005-10-25       Impact factor: 22.113

2.  STAT4 isoforms differentially regulate Th1 cytokine production and the severity of inflammatory bowel disease.

Authors:  John T O'Malley; Rajaraman D Eri; Gretta L Stritesky; Anubhav N Mathur; Hua-Chen Chang; Harm Hogenesch; Mythily Srinivasan; Mark H Kaplan
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

Review 3.  T follicular helper cell programming by cytokine-mediated events.

Authors:  Kaitlin A Read; Michael D Powell; Kenneth J Oestreich
Journal:  Immunology       Date:  2016-08-16       Impact factor: 7.397

Review 4.  T-bet employs diverse regulatory mechanisms to repress transcription.

Authors:  Kenneth J Oestreich; Amy S Weinmann
Journal:  Trends Immunol       Date:  2011-11-29       Impact factor: 16.687

5.  T cell receptor-mediated activation of p38{alpha} by mono-phosphorylation of the activation loop results in altered substrate specificity.

Authors:  Paul R Mittelstadt; Hiroshi Yamaguchi; Ettore Appella; Jonathan D Ashwell
Journal:  J Biol Chem       Date:  2009-03-25       Impact factor: 5.157

6.  Loss of IRF-4-binding protein leads to the spontaneous development of systemic autoimmunity.

Authors:  Jessica C Fanzo; Wen Yang; So Young Jang; Sanjay Gupta; Qinzhong Chen; Ayesha Siddiq; Steven Greenberg; Alessandra B Pernis
Journal:  J Clin Invest       Date:  2006-02-09       Impact factor: 14.808

Review 7.  Cytokine control of inflammation and repair in the pathology of multiple sclerosis.

Authors:  Jane M Rodgers; Stephen D Miller
Journal:  Yale J Biol Med       Date:  2012-12-13

Review 8.  Interferon-γ: teammate or opponent in the tumour microenvironment?

Authors:  Angela M Gocher; Creg J Workman; Dario A A Vignali
Journal:  Nat Rev Immunol       Date:  2021-06-21       Impact factor: 53.106

9.  Impact of Anesthetics on Immune Functions in a Rat Model of Vagus Nerve Stimulation.

Authors:  Chloé A Picq; Didier Clarençon; Valérie E Sinniger; Bruno L Bonaz; Jean-François S Mayol
Journal:  PLoS One       Date:  2013-06-26       Impact factor: 3.240

10.  Activation associated ERK1/2 signaling impairments in CD8+ T cells co-localize with blunted polyclonal and HIV-1 specific effector functions in early untreated HIV-1 infection.

Authors:  Timothy Q Crawford; Fredrick M Hecht; Christopher D Pilcher; Lishomwa C Ndhlovu; Jason D Barbour
Journal:  PLoS One       Date:  2013-10-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.